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Artificial neural networks are a form of artificial computer 
intelligence that have been the subject of renewed research 
interest in the last 10 years. Although they have been used 
extensively for problems in engineering, they have only recently 
been applied to medical problems, particularly in the fields of 
radiology, urology, laboratory medicine and cardiology. An artifi- 
cial neural network is a distributed network of computing ele- 
ments that is modeled after a biologic neural system and may be 
implemented as a computer software program. It is capable of 
identifying relations in input data that are not easily apparent 
with current common analytic techniques. The functioning artifi- 
cial neural network's knowledge is built on learning and experi- 
ence from previous input data. On the basis of this prior 
knowledge, the artificial neural network can predict relations 
found in newly presented ata sets. In cardiology, artificial neural 
networks have been successfully applied to problems in the 
diagnosis and treatment of coronary artery disease and myocar- 
dial infarction, in electrocardiographic nterpretation and detec- 
tion of arrhythmias and in image analysis in cardiac radiography 
and sonography. This report focuses on the current status of 
artificial neural network technology in cardiovascular medical 
research. 
(J Am CoU Cardiol 1996;28:515-21) 
Clinical decision-making is a challenging, multifaceted process. 
Its goals are precision in diagnosis and institution of efficacious 
treatment. Achieving these objectives involves access to perti- 
nent data and application of previous knowledge to the 
analysis of new data in order to recognize patterns and 
relations. This process may be difficult because the data may be 
incomplete, imprecise or unavailable. Additionally, the analy- 
sis may be incomplete or imprecise, particularly if the data are 
viewed through a limited or incorrect window. 
In clinical settings, cardiologists gather diagnostic data in 
several formats, including medical history, physical examina- 
tion, electrocardiograms (ECGs), echocardiograms, nuclear 
studies and cardiac catheterization a d angiographic studies. 
Practitioners apply various tatistical techniques in processing 
these data to assist in clinical decision-making and to facilitate 
the management of patients. As the volume and complexity of 
these data have increased, use of digital computers to support 
data analysis has become a necessity. In addition to comput- 
erization of standard statistical analysis, several other tech- 
niques for computer-aided data classification and reduction, 
generally referred to as artificial intelligence, have evolved. 
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One promising new artificial intelligence technique being 
applied to cardiovascular medicine isthe developing science of 
artificial neural networks. This article describes the computer 
technology ofartificial neural networks and reviews the current 
utilization of artificial neural network technology in clinical 
cardiovascular research. 
Art i f i c ia l  Neura l  Network  Techno logy  
Artificial neural networks are computational tools for pat- 
tern recognition that have been the subject of renewed re- 
search interest during the past 10 years. Artificial neural 
networks, employing several formats and learning algorithms, 
are being used in academic research and industrial applica- 
tions. Research in neural networks began in the 1940s but had 
a brief decline in the late 1960s, when Minsky (1) showed that 
the artificial neural networks available at that ime were unable 
to solve simple problems. Recently, artificial neural network 
research as been revitalized by the advent of new learning 
models. The field continues to grow, and a wide variety of 
network formats and learning rules are being explored. 
Functional elements of artificial neural networks. An ar- 
tificial neural network uses computer technology to model a 
biologic neural system both structurally and functionally. Like 
its biologic counterpart, an artificial neural network is a highly 
interconnected network of a large number of simple processing 
units (2). Figure 1 shows the architecture of a simple neural 
network with four inputs, one hidden layer and two outputs. 
The hidden and output layers process multiple inputs to 
produce outputs. Each processing unit in the hidden layer 
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Figure 1. Diagram illustrating the architecture of a simple feed 
forward neural network with four inputs and two outputs. The network 
has three "hidden" neurons. These neurons are responsible for the 
pattern recognition capability associated with the network. Signals are 
presented tothe input neurons, which weight them and pass them to 
the hidden layer. The hidden layer neurons sum the weighted signals 
and pass the sum through a transfer function. The transformed signals 
are then passed to the output neuron through the weighted connec- 
tions (lines) between the hidden and output layers. The output neuron 
sums these weighted signals and passes this summed signal through its 
transfer function. This transformed signal becomes the output of the 
network. Circles = neurons. 
multiplies each initial input by the associated connection or 
synaptic weight derived from the training phase. These are 
subsequently summed in each hidden processing unit and 
passed through a transfer function that scales the output o a 
value within a limited range (e.g., between 0 and 1). The output 
then becomes an input for the next layer. In this simple 
example, the next layer is the output layer. The output layer 
processing units then multiply the inputs from the hidden layer 
with the weights connecting the two layers. These resulting 
signals are processed by the transfer functions and become the 
output of the network. In short, each processing unit, or 
neuron, sums weighted inputs and passes the results through a
transfer function on to the next level neuron, which finally 
activates the output unit and produces the artificial neural 
network output (3). The choice of transfer function allows one 
to tailor to the specific task at hand. Use of logarithmic or 
hyperbolic tangent functions is frequently preferred because 
both functions and their mathematic derivatives are continu- 
ous, a characteristic that simplifies many artificial neural 
network training algorithms. These nonlinear characteristics 
provide saturation functions; more excitation above some 
maximal firing level has no further effect on the output. 
Training methods for artificial neural networks. Artificial 
neural networks can be divided into two main classes--those 
using supervised learning and those employing unsupervised 
learning. Supervised learning techniques, which are used most 
commonly, associate inputs with learned outputs. Unsuper- 
vised learning is generally used for data base classification. 
For supervised learning, a network is trained rather than 
programmed. Most commonly, a neural network is trained by 
the process of back propagation, although alternative pro- 
cesses, such as cascade correlation and general regression, are 
available. In back propagation training, a technique first 
introduced by Rumelhart et al. (4) in 1986, the network is 
presented with a set of input values and an associated set of 
output values. The network is required to set interlayer weights 
that provide correct output functions for each case in the set. 
An error occurs when there is a discrepancy between the 
network's output and the true output for a training set. Errors 
occur because the interlayer weights are not correct. A learn- 
ing rule then causes the network to change its connection 
weights to more closely approximate he true output. Thus, an 
error determines a weight modification and allows the network 
to learn by modifying its interlayer weights. At the end of the 
training process, the connecting weight patterns represent the 
final values that associate inputs to outputs for a given data 
base. An alternative l arning algorithm, cascade correlation, 
trains one hidden unit at a time and adds units as needed to 
minimize output error. This is a somewhat faster training 
algorithm than the back propagation method. 
After training the network, testing for learning and gener- 
alization, rather than memorization, is performed by using a 
test set. Generalization is the ability of the trained neural 
network to produce a correct output for input that it has not 
seen previously. Generalization is tested for by presenting test 
data unknown to the neural network and evaluating the neural 
network output with respect o the known actual output of the 
test data. If there is agreement between the actual output and 
the neural network output, generalization a d learning have 
been successful. 
Currently, neural network architectures are derived primar- 
ily by trial and error, although rules for neural network 
optimization are under development. Decisions about the 
number of neurons in a hidden layer, the number of hidden 
layers in use, the pattern of neuron connections and the types 
of transfer functions are largely an empiric process. 
Neural networks provide an approach to data analysis that 
uses mathematic pattern recognition. Artificial neural net- 
works learn complex interactions among inputs and produce 
an output as they train on a known set of data. Artificial neural 
networks use this training to produce an output for new inputs. 
Artificial neural networks are thus capable of identifying 
relations in input data not apparent to human analysis. In a 
broad sense, an artificial neural network develops "clinical 
judgment" based on previous learning and experience. 
Neural network technology has been widely applied to 
problems in engineering and computers. Recently, medical 
applications have been developed in various fields, including 
cardiology, radiology, urology and laboratory medicine. The 
remainder of this report will focus on the current status of 
neural network technology in cardiovascular medicine. 
Artificial Neural  Networks in 
Cardiovascular Medic ine 
The science of artificial neural networks has been applied in 
efforts to solve several problems in four general areas of 
cardiovascular medicine. These areas are: coronary artery 
disease, electrocardiography, cardiac image analysis and car- 
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liovascular drug dosing. The artificial neural network reports 
elating to coronary artery disease may be divided into those 
tddressing the general diagnosis and treatment of coronary 
trtery disease and those specifically related to acute myocar- 
lial infarction. The ECG studies are concerned with general 
2CG interpretation, arrhythmia dentification and arrhythmia 
ocalization. A small number of studies (5-7) have also been 
mblished that relate artificial neural networks to miscella- 
neous areas of interest to the cardiovascular specialist. 
Coronary artery disease. Diagnosis and treatment. Millions 
ff patients present each year for evaluation of symptoms of 
:oronary artery disease. The initial evaluation typically in- 
',ludes analysis of history and physical as well as noninvasive 
esting for ischemia. The relations among these clinical and 
loninvasive variables are often subtle and complex. Currently, 
:oronary artery disease is assessed by several noninvasive 
nethods, including exercise stress testing, nuclear imaging and 
~chocardiography. There are many limitations to these tech- 
lologies, including time requirements and patient inconve- 
lience. In addition, gender differences in sensitivity and spec- 
ficity can limit diagnostic accuracy. For example, women have 
l higher ate of false positive xercise ECGs than do men, and 
)reast attenuation is a problem in nuclear imaging studies. A 
echnology that could minimize these limitations would be 
)eneficial in the diagnosis and treatment of coronary artery 
tisease. Alternatively, a technology that could take into ac- 
:ount the limitations of noninvasive testing and combine the 
loninvasive results with the history and physical variables 
vould also be extremely useful in the clinical setting. Investi- 
gators are exploring the potential of artificial neural networks 
o achieve these goals. 
Akay (8) utilized history and physical examination data, as 
yell as preprocessed recordings of diastolic heart sounds, to 
tiagnose coronary artery disease with a back propagation 
:rained artificial neural net. The positive predictive accuracy 
vas 84% and the negative predictive accuracy was 89% in this 
;tudy of 63 abnormal and 37 normal subjects. 
Our group (9) also assessed the significance of coronary 
trtery disease by using an artificial neural network. We trained 
personal computer-based artificial neural network, using 
~ack propagation oferrors in a single layer, to identify patients 
vith significant coronary artery disease on the basis of 23 
mninvasive variables. These variables included history and 
~hysical examination data as well as results of noninvasive 
esting such as exercise treadmill testing. The artificial neural 
letwork was trained to recognize significant coronary artery 
lisease, defined as >50% obstruction ofthe left main coronary 
trtery or other epicardial vessels. We identified significant 
:oronary artery disease with a positive predictive accuracy of 
~0% and a negative predictive accuracy of 92%. It appeared 
'rom that study that artificial neural networks may be useful in 
~xcluding patients with significant coronary artery disease and 
:ould potentially eliminate the need for further invasive testing 
n these patients. 
There has been one report of artificial neural network use 
:o facilitate treatment ofcoronary artery disease. In a study by 
Gindi et al. (10), tissue fluorescence spectra were analyzed 
with the use of an artificial neural network to assist with 
laser angioplasty procedures by helping to differentiate normal 
from abnormal atherosclerotic ssue. In that study, a back 
propagation-trained artificial neural network was useful in 
distinguishing normal from abnormal tissue. 
Artificial neural networks at this time do not significantly 
improve current noninvasive technologies for diagnosing and 
treating coronary artery disease. With continued research, 
roles for such networks may be developed. For example, they 
may become useful in risk stratification of patients who present 
with unstable angina, and the technology may ultimately assist 
in identifying patients who will respond to medical therapy. 
Acute myocardial infarction. In the era of health care 
reform, when cost containment efforts are being mandated by 
both governmental and private third-party payers, the accurate 
detection of acute ischemic heart disease in patients presenting 
to the emergency room with chest pain of suspected cardiac 
origin and a nondiagnostic ECG has become particularly 
important. Artificial neural networks have been tested for 
identifying patients with cardiac chest pain and more specifi- 
cally those with acute myocardial infarction. 
In one of the first studies of this subject, Baxt (11) retro- 
spectively analyzed 356 patients admitted to a coronary care 
unit with chest pain. With the history, physical examination 
findings and ECG data, Baxt used back propagation totrain a 
neural network to identify patients with myocardial infarction. 
He validated the diagnosis of myocardial infarction with 
confirmatory serum enzyme levels or with an ECG showing 
new pathologic Q waves. The network correctly identified 92% 
of patients with and 96% of patients without a myocardial 
infarction. 
In a subsequent study, using the artificial neural network 
trained on the initial patients, Baxt (12) prospectively studied 
331 adult patients with precordial chest pain. He compared 
diagnostic sensitivity (True positives/True positives + False 
negatives) and specificity (True negatives/True negatives + 
False positives) between attending emergency room physicians 
and neural networks in identifying the diagnosis of acute 
myocardial infarction. The physicians had a diagnostic sensi- 
tivity of 78% and a specificity of 85%, whereas the neural 
network had a sensitivity of 97% and a specificity of 96%. Baxt 
(13) further evaluated the process by which the artificial neural 
network diagnosed myocardial infarction. The most important 
diagnostic variable was the presence of ST segment depression 
or elevation in the admission ECG. More interesting was the 
finding that the network predicted infarction by placing more 
diagnostic importance on the finding of tales on auscultation 
than on the patient's age and gender or a history of hyperten- 
sion or diabetes mellitus. Rales as a clinical finding had not 
previously been shown to be predictive of infarction. 
Other investigators have evaluated the use of artificial 
neural networks for the diagnosis of myocardial infarction. 
Furlong et al. (14) used analysis of cardiac enzyme data to 
diagnose myocardial infarction. The artificial neural network, 
trained by back propagation ofcardiac enzyme data, was used 
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to identify 24 patients with and 29 patients without acute 
myocardial infarction. The positive predictive accuracy was 
100% and the negative predictive accuracy 93%. 
These studies uggest that an artificial neural network may 
be able to find a useful pattern in the unique combination of
signs, symptoms and laboratory results that each patient brings 
to the clinical encounter. With this ability, it appears that 
artificial neural networks can be used to assist in the evaluation 
of cardiac chest pain and in the diagnosis of myocardial 
infarction and to bring a greater level of confidence to this 
process. 
Electrocardiography. General interpretation. For many 
years computer technology has been used in the analysis and 
interpretation of ECGs (15,16). Recently, artificial neural 
network technology has been incorporated into the efforts for 
automated analysis and interpretation. Bortolan et al. (17) 
compared artificial neural network interpretation f ECGs to 
statistical analysis of conventional linear discriminant analysis 
and multigroup logistic discriminant analysis. Edenbrandt et 
al. (18) evaluated artificial neural network ECG ST-T segment 
classification and compared it with clinical interpretation. They 
found that artificial neural network classification accuracy was 
80%, when compared with the classification of experienced 
cardiologists. 
Although interesting preliminary studies have been re- 
ported in this area, few have had clinical relevance, and to date 
no work has shown the feasibility of artificial neural networks 
performing routine ECG analysis. Suzuki and Ono (19) 
showed the most promising use of an artificial neural network 
in the automation of interpretations in a noisy ECG record. 
This application seems to have a potentially wide utility but 
needs to be studied further. 
A more fruitful area of research is the use of artificial 
neural networks in the ECG diagnosis of myocardial infarc- 
tion. Heden et al. (20) studied the ability of artificial neural 
networks to make the diagnosis of myocardial infarction from 
the analysis of the ECGs of 1,107 patients who had undergone 
diagnostic ardiac catheterization. The performance of the 
artificial neural networks in the diagnosis of anterior and 
inferior myocardial infarction was compared with the conven- 
tional automated ECG interpretation with the Glasgow pro- 
gram (15). For anterior infarction, the artificial neural network 
sensitivity was 81% and the conventional program sensitivity 
68%. For inferior infarction, the artificial neural network 
sensitivity was 78% and the conventional program sensitivity 
66%. Artificial neural network interpretation f anterior and 
inferior myocardial infarction appears to be more sensitive 
than the Glasgow program, a frequently utilized rule-based 
computer system. Yang et al. (21) demonstrated that using a 
back propagation eural network in combination with the 
deterministic Glasgow program yielded better diagnostic out- 
comes for inferior wall myocardial infarction than did either 
the deterministic program or the neural network used alone. 
Arrhythmia identification. There are numerous studies us- 
ing artificial neural network for arrhythmia detection, identi- 
fication and treatment. Yang et al. (22) evaluated artificial 
neural networks as an aid to improving the sensitivity and 
specificity of a commercial ECG interpretation program (15) 
in diagnosing atrial fibrillation. Only minor differences were 
noted in the sensitivities and specificities of the commercial 
program alone, the artificial neural network and the combina- 
tion of commercial program and artificial neural network. The 
initial conclusion was that utilization of an artificial neural 
network did not lead to any appreciable gains in the diagnosis 
of atrial fibrillation, although several years of development 
were required to achieve the degree of precision present in the 
deterministic program. In a subsequent report, Yang et al. (23) 
suggest hat the artificial neural network technique can im- 
prove the deterministic logic program's sensitivity from 88.5% 
to 92% without losing specificity (92.3%). 
An important use of artificial neural networks may be in the 
accurate identification ofventricular tachycardia. In a study by 
Dassen et al. (24), a back propagation artificial neural network 
correctly identified 95% of ventricular tachycardias. The clin- 
ical utility of this process was limited because the input data 
were not automated. Manual measurements of ECG variables 
and subsequent neural net input is a more cumbersome 
process than simple visual interpretation i  the immediate 
clinical setting. Lee (25) described a rate of ventricular tachy- 
cardia identification >95% with the use of an artificial neural 
network. The importance of this study may be in the ap- 
plication of this artificial neural network to implantable 
cardioverter-defibrillators. The sensing characteristics of the 
device, which enable it to recognize awide range of arrhyth- 
mias, are crucial to the delivery of appropriate shocks. Current, 
implantable cardioverter-defibrillators userate-based systems, 
which have limitations in the identification of the origin of the 
tachyarrhythmia. 
In a study by Farrugia et al. (26), a traditional rate-based 
classifier was compared with an artificial neural network 
sensed event classifier to evaluate both waveform configuration 
and heart rate variability. The artificial neural networks pro- 
duced significantly better results than did the conventional 
rate-based classifiers. The absolute rror rate (percent of the 
total number of patterns misclassified) was 7.1% for the 
artificial neural networks in contrast to 17% for the rate-based 
system. Ventricular tachycardia was also more effectively dis- 
criminated from sinus tachycardia by the artificial neural 
networks. Thus, artificial neural network-based systems that 
considered waveform configuration of the ventricular intracar- 
diac ECGs in conjunction with rate were superior in arrhyth- 
mia recognition to rate-based systems alone. Iwata et al. (27) 
have used neural network technology to compress ECG data 
for more efficient ambulatory ECG (Holter) monitor function- 
ing. 
Arrhythmia localization. Radiofrequency atheter ablation 
has become the treatment of choice for patients with symp- 
tomatic or life-threatening cardiac arrhythmias related to 
preexcitation syndromes and accessory pathways. Currently, 
the initial noninvasive localization of accessory pathways is 
based on clinical interpretation of surface ECGs. However, 
because this method is nonspecific and successful catheter 
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ablation is dependent on highly accurate localization of the 
bypass tract, a more accurate preprocedure method of local- 
ization is required. Additionally, accurate localization can 
potentially minimize procedure time and radiation exposure to 
both the patient and the operator. In this area artificial neural 
networks have been tested and show great promise. 
Morytko et al. (28) evaluated the use of artificial neural 
networks to localize accessory pathways before performing 
radiofrequency ablation. Artificial neural networks were 
trained with retrospective data from 60 patients who had 
undergone ablation. The output of each of the networks 
indicated the presence or absence of the accessory pathway site 
for which the network was trained. The networks were then 
applied to eight random patients not used in training. Acces- 
sory pathway locations were localized with a sensitivity of 75% 
and specificity of 100%. The positive predictive value was 95% 
and overall accuracy 96%. 
Dassen et al. (29) also used an artificial neural network to 
localize atrioventricular ccessory pathways in patients with 
the Wolff-Parkinson-White syndrome. After the artificial neu- 
ral network was trained on manually generated ata from 60 
cases, 25 cases were used to test the network. The network 
interpreted 23 cases correctly. In 15 cases, predicted locations 
and actual ocations were exact fits; in 8 cases, a border zone 
between two locations was predicted by the network; and in 2 
other cases, prediction was incorrect. The investigators con- 
cluded that artificial neural networks can be useful in these 
types of studies even where causal relations between physio- 
logic mechanisms and ECG findings are only partially under- 
stood. 
In the area of arrhythmia localization, artificial neural 
networks how the potential to analyze subtle, complex ECG 
patterns and to successfully predict accessory pathway location 
and determine the focus of ventricular tachycardia. This area 
of investigation isexciting and offers great promise. By refining 
the technique of ablation with preprocedure localization of an 
accessory pathway, artificial neural networks can potentially 
reduce procedure time, minimize radiation exposure and avoid 
ineffective energy applications and increase overall success 
rates. 
Cardiac image analysis. Noninvasive imaging data includ- 
ing stress echocardiographic images and nuclear scintigraphic 
images require computer preprocessing before interpretation. 
The importance of preprocessing is illustrated by the technol- 
ogy of automated border detection. Proponents of automated 
border detection state that it can offer pathophysiologic in- 
sights and improve clinical and perioperative management of
patients with acute and chronic coronary syndromes, conges- 
tive heart failure and valvular heart disease (30). The utility of 
automated border detection can be illustrated in the interpre- 
tation of stress echocardiography. Standard, subjective visual 
interpretation of wall motion changes may be enhanced and 
made more sensitive by automated border detection. Artificial 
neural networks are under investigation i the fields of image 
processing and interpretation. They are being used to process 
images, to facilitate complex pattern recognition, which will aid 
classification of images into clinically relevant categories. 
In medical applications outside of cardiology, artificial 
neural networks have been trained to recognize lesions imaged 
on mammography asbenign or malignant, hepatic ultrasound 
images and avascular necrosis of the femoral head in magnetic 
resonance images (1). In cardiovascular pplications investiga- 
tors are using artificial neural networks to automate the 
segmentation and recognition of structures or regions of 
interest in echocardiographic and scintigraphic images. 
Cios et al. (31) evaluated echocardiographic images by 
neural networks for separation into regions of interest for 
diagnosis. The investigators found specificities of >70% for all 
diagnostic lasses such as hypertrophic ardiomyopathy and 
posterior myocardial infarction. Using a similar concept, Fujita 
et al. (32) found that a neural network analyzed thallium-201 
myocardial single-photon emission computerized tomographic 
bull's-eye images to make a corresponding diagnosis. The 
diagnosis was more accurate than that of a junior resident but 
less accurate than that of a staff radiologist. The accuracy rate 
was 77% for an artificial neural network, 69% for a junior 
resident and 83% for a staff radiologist. The data from these 
investigators are preliminary but appear promising with further 
refinements. 
Cardiac drug dosing. One important goal of clinical deci- 
sion making is the institution of efficacious treatment. Studies 
concerning the effectiveness of artificial neural networks as 
drug therapy monitors have been reported. Poll et al. (7) 
describe "Hypernet," an artificial neural network-based sys- 
tem that utilizes 24-h blood pressure monitor input to diagnose 
and analyze therapeutic interventions for ambulatory hyper- 
tensive patients. In a test set of 35 patients (10 normotensive 
and 25 hypertensive), the therapeutic recommendations of 
Hypernet were tested against hose of an experienced special- 
ist. In this comparison, Hypernet achieved a sensitivity of 92% 
and a specificity of 96% when evaluated for both diagnosis and 
treatment efficacy. 
Narayanan and Lucas (33) reported the result of an artifi- 
cial neural network utilized to assist the physician in choosing 
a warfarin dose to optimize patients' international normalized 
ratio. This type of program may help shorten hospital stay, for 
example in patients who have had coronary artery stent 
placement. These studies illustrate the potential of artificial 
neural networks in tailoring pharmacotherapy. 
Other areas of research. Several reports on neural net- 
works have been published in miscellaneous areas of interest 
to cardiovascular medicine. Scott and Palmer (5) reported the 
use of artificial neural networks in the interpretation of 
ventilation-perfusion lu g scans. Ebell (6) described their use 
for predicting the outcome of in-hospital cardiopulmonary 
resuscitation. Lette et al. (34) suggested that artificial neural 
networks may be useful in predicting cardiac complications 
after noncardiac surgery. Tu and Guerriere (35) used an 
artificial neural network to predict length of stay in the 
intensive care unit after cardiac surgery. Foo et al. (36) used an 
artificial neural network to detect the lack of heart rate 
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variability, a viable index to predict sudden cardiac death. 
Cathers (37) described the development of a neural network- 
based classifier for phonocardiographic output. Georgiadis et 
al. (38) recently described a neural network-based analysis of 
Doppler signals representing microemboli n patients with 
prosthetic cardiac valves. 
through the wrong window. At the very least, artificial neural 
networks open a new window. 
We express our appreciation to Bernard J. Gersh, MB, ChB, DPhil, FACC, 
Donald F. Leon, MD, FACC, and Enrique Mendez, Jr., MD, FACP for their 
reviews and helpful suggestions in the preparation of the manuscript. 
Discuss ion  
Artificial neural networks are a new application of com- 
puter technology. They have varied utilization in current 
cardiovascular medical research, but there are current limita- 
tions to the technology. Artificial neural network techniques 
are initially cumbersome. It is time-intensive to collect and 
preprocess data and to train the networks. Once training is 
completed, further tasks can be carried out with relative ease. 
Another limitation is that, unlike rule-based systems, the 
artificial neural networks cannot easily explain their reasoning. 
Many clinicians may have dilficulty putting faith in a "black 
box" whose logic is not clear. However, clinical medicine 
comprises empiric observations. Clinicians use empiric data 
and "clinical judgment" to make clinical decisions on a daily 
basis. As one reviewer of this technology (39) wrote, "Artificial 
neural networks should not be considered to be mystical black 
boxes. The only mystery lies in how something so simple, such 
as a network of elementary decision nodes, can solve problems 
as complex as the diagnosis of an myocardial infarction or the 
interpretation of a V/O scan." 
A third limitation of this technology, particularly of back 
propagation training methods, is its restricted range. The 
technique performs best in the setting of a well defined 
problem with a limited number of diagnostic options--for 
example, the presence or absence of a myocardial infarction. 
This can be a limitation in that in many diagnostic problems, 
multiple disorders may be present concurrently. An excellent 
example of this problem is illustrated in the study by Yang et 
al. (21) in which the presence of left ventricular hypertrophy 
reduces the specificity of a neural network in the diagnosis of 
inferior wall myocardial infarction. 
Artificial neural networks are not meant to replace clinical 
judgment or classic statistical approaches; they are meant to 
enhance clinical decision-making. Though they are relatively 
new, they are one of a number of techniques for interpreting 
cardiovascular medical data. One value of artificial neural 
networks as a new tool may be that they can be developed 
relatively quickly if data are available, as opposed to certain 
deterministic logistic programs which, as pointed out by Mac- 
farlane and Yang and their co-workers (15,22,23), may require 
significantly more developmental time. Another potential 
value of the newly developing artificial neural network tool 
may be that it assists in recognizing patterns and relations 
among sets of clinical and experimental information that 
previously have not been accessible because of limitations in 
the analytic methods. There may be profound truths that have 
not been appreciated because observers have been looking 
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